Main Article Content

Editorial: Short-course adjuvant trastuzumab will increase cure rates in patients with human epidermal growth factor receptor 2-positive breast cancer


Raymond P. Abratt

Abstract

No Abstract

Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574